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Murine embryonic stem (ES) cells can be committed to neural differentiation with high efficiency in culture through the use of feeder- and
serum-free media. This system is proving to be an excellent model to study processes involved in ES cell commitment to neural cell fate. We used
this approach to generate neurogenic embryoid bodies (NEBs) in a serum-free culture system to perform proteomic analysis of soluble fractions
and identify early changes in protein expression as ES cells differentiate. Ten candidate proteins were altered significantly in expression levels.
One of the most significant alterations was for the small heat shock protein Hsp25. Three species of Hsp25 are detected in ES cells, and this
expression pattern changes during the first 24 h of differentiation until expression is decreased to levels that are barely detectable at 4 days
following differentiation. We used immunofluorescence studies to confirm that following ES cell differentiation, expression of Hsp25 becomes
excluded from neural precursors as well as other differentiating cells, making it a potentially useful marker of early ES cell differentiation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Mouse embryonic stem cell; Neural differentiation; Hsp25 protein1. Introduction
The differentiation of embryonic stem (ES) cells to neural
precursors has always aroused great interest because of the
potential use of specific neuronal sub-types in replacement
therapies. The in vitro generation of neural progenitors from
mouse ES cells has been reported by several groups. When
cultured in serum- and feeder-free conditions as either
suspension aggregates [1,2] or as a monolayer [3], ES cells
generate a high percentage of neural precursor cells (NPCs).
Early neuroectodermal markers such as Sox1 are expressed in
the majority of cells after 4–5 days in culture. Neural
differentiation under these conditions has been shown to be
dependent on endogenous FGF signalling and active BMP and
Wnt antagonism [2,4]. Recently it has been shown that in very⁎ Corresponding author. Tel.: +44 1248 382341; fax: +44 1248 370731.
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doi:10.1016/j.bbamcr.2006.08.030low-density cultures, ES cells will form primitive neural stem
cells in the absence of extrinsic factors and of endogenous FGF
[5]. The in vitro derived NPCs can differentiate into neurons,
astrocytes and oligodendrocytes [1–3].
Here we use a previously described model [2,6] in which ES
cells undergo in vitro neural differentiation as neurogenic
embryoid bodies (NEBs) in chemically defined media (CDM).
While the ability to generate NPCs from ES cells has been
demonstrated, we sought to identify molecular events associated
with the early transition of ES cells. There is currently limited
information on the cell intrinsic mechanisms of ES cell
differentiation, making the identification of early events an
essential undertaking. We report the use of the NEB system in a
comparative proteomic analysis to identify changes in the
proteome that occur during commitment of mouse ES cells,
primarily to a neural fate. Specifically, we employed the use of
difference gel electrophoresis (DIGE), which allows protein
differences between two samples to be analysed on the same gel.
This approach avoids problems associated with reproducibility
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DIGE applications have attained high levels of accuracy in
quantification) and has markedly reduced false positive
identifications compared to other methods, giving high
confidence levels to candidates [7,8]. We demonstrate that ES
cell differentiation in CDM is characterized by the depletion of
Hsp25. Hsp25 (HspB1, Hsp27 in human) is a member of the
small heat shock protein (Hsp) family of proteins that are
expressed in response to a range of cellular insults [9].
Differential expression and/or phosphorylation of Hsp25 has
been identified in a number of differentiation processes, for
example cardiomyocyte differentiation in P19 EC cells and
endodermal differentiation in CGR8 ES cells [10,11]. This is
the first proteomic study to analyse Hsp25 levels in murine ES
cells as they differentiate along a predominantly neural
pathway when cultured in CDM, and demonstrates a unique
pattern of Hsp25 expression compared to that studied in other
differentiation systems. We demonstrate that changes in a
specific set of Hsp25 species are associated with the
differentiation of ES cells in culture to primarily form NSCs.
Furthermore, we show that in NEB cultures, Hsp25 becomes
excluded from the neural precursor population. The down-
regulation of Hsp25 may be more general following differen-
tiation along alternative lineages since we show that it is also
excluded from a transient non-neural population found in
NEBs. The reduction in Hsp25 occurs before overt expression
of differentiation markers e.g. Sox1, and may therefore be a
useful marker of early murine ES cell differentiation.
2. Methods
2.1. Cell lines
Mouse ES cell line E14 [12]. Line 46 C, in which GFP cDNA is inserted at
the sox1 promoter therefore acting as an indicator of sox1 expression, was a gift
from A. Smith [4].
2.2. Routine cell culture
ES cells were cultured on mouse embryonic fibroblasts (MEFs) in Iscoves
Modified Dulbecco's Medium (IMDM) with 15% FBS (Gibco Invitrogen), 1×
penicillin/streptomycin (Sigma Aldrich), 0.1 mM β-Mercaptoethanol, 1×
Glutamate, 1× non-essential amino acid (Gibco Invitrogen), 1000 U/ml LIF
(Chemicon) at 37 °C, 5% CO2.
2.3. Neural induction and differentiation of murine ES cells
Prior to neural differentiation, ES cells were passaged twice on 0·1% gelatin
at a density between 5×106 cells/100 mm2 dish (<5×104 cells/cm2) and
1.5×107 cells/100 mm2 dish (1.5×105 cells/cm2). To generate NEBs, ES media
was removed, and cells resuspended at 0·5–1.0×105 cells/ml in CDM [IMDM:
Nutrient Mixture Ham's F12 (1:1), 1× Glutamate, 1× Chemically Defined Lipid
Concentrate (Gibco Invitrogen), 1× penicillin/streptomycin, 450 μM mono-
thiolglycerol (Sigma Aldrich), 15 μg/ml transferrin and 7 μg/ml insulin (Roche
Diagnostics Corporation)] in 100 mm2 petri dishes. Media was changed every
2 days.
2.4. Cell lysate preparation for 1 and 2D gel analysis
FACS analysis using antibody to Oct4 (pluripotency marker) and Nestin
(neural precursor marker) was routinely carried out prior to proteomic analysisto confirm cell differentiation. E14 ES cells were resuspended in 40 mM Tris
pH 8 with protease inhibitors (10 μM E-64, 10 μM PMSF, 2 μg/ml aprotinin,
1 μM pepstatin, 10 μM bestatin, 100 μM leupeptin) to a density of 20,000
cells/μl (concentration suitable for Cy dye labeling). NEBs: Spheres were
harvested by centrifugation (500 r.p.m./3 min), to remove dead cells and cells
that had not formed spheres (for 6 h NEBs, cells were harvested at 1000 r.p.m./
3 min). Cells were resuspended in 40 mM Tris pH 8 with protease inhibitors (as
above) to a density of 20,000 cells/ μl. For lysis, ES cells were sonicated for a
total of 25 s (maximum of 10 second bursts) and NEBs for 30 s. Samples were
quantified using a standard Bradford assay (Sigma Aldrich). For non-DIGE
gels, an equal volume of 2× sample buffer (8 M Urea, 4% CHAPS, 20 mg/ml
DTT, 10 mM Tris pH 8) was added and incubated at room temperature for
15 min. The volume was made up to 300 μl with rehydration buffer (8 M Urea,
4% CHAPS, 2 mg/ml DTT, 10 mM Tris pH 8) and 1.2% pH 3–10 Bio-lytes
(Bio-Rad) added. Samples were loaded on the Protean Cell IEF (Bio Rad)
machine for the 1st dimension separation. For DIGE gels, samples were labeled
as below.
2.5. DIGE experimental design
For each time point, four DIGE gels were run using sample from two
independent experiments. Two gels were run for each experiment, the first gel
consisting of the samples labeled with Cy dye in a ‘forward’ combination (i.e.
Cy3 labeled ES sample and Cy5 labeled neurosphere sample) and the second gel
consisting of the samples labeled with the reciprocal or ‘reverse’ combination
(i.e. Cy5 labeled ES sample and Cy3 labeled neurosphere sample). In this
approach, ES cell derived protein acted as the control sample to which the
neurosphere sample was compared. The dye combinations allow any dye
specific artefacts to be accounted for.
2.6. Cy dye labeling
Samples were labeled with Cy3 and Cy5 fluorescent dyes, Amersham
Biosciences. 75 μg protein in 40 mM Tris pH 8 was labeled with 200
pmole dye (solubilised in anhydrous dimethyl formamide), for 30 min (in
the dark), 4 °C. Labeling was stopped with 10 mmol lysine, 10 min (dark),
4 °C. An equal volume of 2× sample buffer was added to the samples and
incubated in the dark for 15 min at room temperature. The volume was
made up to 300 μl with rehydration buffer (8 M Urea, 4% CHAPS, 2 mg/ml
DTT, 10 mM Tris pH 8) and 1.2% pH 3–10 Bio-lytes were added. Samples
were then loaded for isoelectric focussing (IEF) and separated as described
below.
2.7. 2D gel electrophoresis
1st D: IEF was performed using the Protean Cell IEF (Bio Rad), with 17 cm
IPG strips, pH 5–8 or 4–7. [Preliminary gels using broad range pH (3–10), data
not shown, showed that the majority of detectable and therefore mass
spectrometer identifiable spots lay within the 5–8 pH range, and to a lesser
extent the 4–7 pH range. We therefore focused on these two ranges of pH,
although all difference spots subsequently referred to were identified in the 5–
8 pH range]. Active rehydration of strips was performed at 50 V/10 h, the
voltage was then increased to 10,000 Vover a 2 h period. The IEF was run for
50,000 Vhrs. The strips were then equilibrated in Equilibration buffer 1 (6 M
Urea, 2% SDS, 0·375 M Tris–HCl pH 8·8, 20% Glycerol, 2% DTT, 0·2 mg/ml
Bromophenol blue) for 15 min, followed by 20 min in Equilibration buffer 2
(6 M Urea, 2% SDS, 0·375 M Tris–HCl pH 8·8, 20% Glycerol, 2·5%
Iodoaceamide, 0·2 mg/ml Bromophenol blue). 2nd D SDS-PAGE: strips were
transferred to 1·5 mm, 12% homogeneous SDS-PAGE resolving gels with 4%
stacking gels, and sealed with 0.5% LMP agarose on the Bio-Rad Protean II xi
cell. Gels were run at 120 V through the stacking gel and 200 V through
resolving gel.
2.8. Image acquisition of DIGE gels
Gels were imaged in the ProXpress multiwavelength imager (Perkin Elmer)
(using edge illumination). Cy3 was excited at 540 nm and fluorescence detected
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detected through the 680 nm filter. Resolution was set to 100 μm. The
exposure time was set such that maximum pixel intensity reached 40,000–
60,000 pixels. Images were exported as TIFF files into Phoretix v5·1
(Nonlinear Dynamics) for analysis. Corresponding images from a DIGE gel
were analysed using Phoretix v5.1. For each gel, two images were generated,
representing the ES and neurosphere populations. Images from the same gel
were processed together to ensure that gel processing and spot detection was
performed using identical parameters. Images were matched and adjusted so
that corresponding spots had identical spot boundaries, ensuring that
subsequent differences in spot volume only reflected changes in pixel
intensity. Any spots that could not be identified as being real with 100%
certainty were deleted. This was particularly relevant for small, faint spots,
which can be hard to distinguish from image artefacts. It is unlikely that the
low quantities of protein associated with faint spots would be successfully
identified by MS, so their removal is viewed as having little impact on the
screen. Furthermore, removal of small, faint spots should strengthen the
quality of gel analysis since the accuracy of DIGE quantification decreases
with spot volume. Using this method an average of 175 confirmed and
matched spots were detected in each gel. Following spot matching, the gels
were normalized and the normalized spot volumes for every spot were
transferred to Excel, where normalized spot volume ratios were calculated.
Therefore for every spot detected, a normalized spot volume ratio was
obtained that represented the relative abundance levels for that spot between
the ES and neurosphere populations. Using differential in-gel analysis (DIA)
only normalized spot volumes of corresponding spots between images from
the same gel can be compared and quantified; using DIA it is not possible to
create expression ratios for corresponding spots between different gels. As
such, the normalized spot volume ratios for corresponding spots in different
gels was collated to identify the spots showing consistent, significant changes
throughout the gels. Of the spots analysed, 10 spots had normalized spot
volume ratios that were consistently above the threshold values (determined
below) in the neurosphere samples compared to the ES cells.
2.9. Derivation of threshold values in DIGE gels
The DIGE experimental design used here is known as differential in-gel
analysis (DIA). Using DIA, necessitates the use of control gels to allow
assessment of experimental variation within the system, allowing significance
thresholds to be assigned to the normalized spot volume ratios. The control gels
run consisted of two equal quantities of ES cell sample together, one labeled
with Cy3 and the other with Cy5. As the samples were identical, any difference
in corresponding spot volume ratios represents experimental variation. By
plotting the log normalized spot volumes between corresponding Cy3 and Cy5
spots, a graphical representation of this variation was obtained. (In a perfect
system, all corresponding spot ratios would equal one and lie on the y=x
trendline, but our system was biased in favour of the Cy5 values. Therefore
Cy3 labeled spots must be 1.61 times greater in normalized volume than Cy5
spots to be considered significant, whereas Cy5 labeled spots must be 2.36
times greater in normalized volume than Cy3 spots to be significant). For the
purpose of DIA, Amersham Biosciences recommend setting threshold values
two standard deviations (SD) from the mean of the log normalized spot volume
ratios. Setting these thresholds will result in 95% of the normalized spot
volume ratios falling within the threshold values. Normalized spot volume
ratios falling outside the threshold values can be reasonably expected to
represent biological changes, with a 5% false positive chance of it being an
artefact of system variation.
2.10. Mass spectrometry (MS) analysis of spots
Following gel analysis to identify difference spots, the gels were silver
stained and spots of interest were manually excised. The in-gel protein samples
were automatically digested using a Micromass MassPREP Station. MS
protein analysis was carried out using a Qtof2 (Waters) mass spectrometer.
MassLynx version 3.5 (Waters) was used to create the “peak list” from the raw
data.
The database was searched using MASCOT (Matrix Science Ltd.), with
carbamidomethyl and cystein fixed modification, and oxidation of methionineas a variable modification. The peptide mass tolerance was 1 Da, fragment mass
tolerance, 0.8 Da. Database searching was carried out against the NCBI database
(2003). Interpretation of the MS data was carried out within MASCOT.
2.11. Immunocytochemistry (IC)
ES cells were grown on 13 mm coverslips in 24 well tissue culture dishes
coated with 0·1% gelatin. Coverslips were washed 3 times with PBS and fixed
in 4% paraformaldehyde (PFA) for 10 min at room temperature before being
washed twice in PBS. NEBs were harvested by centrifugation (500 r.p.m./
3 min), washed with PBS, and fixed at 4 °C for 15 min in 4% PFA, before
being washed twice in PBS, resuspended in 30% sucrose (in PBS) overnight at
4 °C and embedded in O.C.T. embedding medium (VWR). Embedded NEBs
were cut into 10–15 μm sections. Immunocytochemistry was performed on ES
cells on coverslips or sections as follows: cells were permeabilised in 0.2%
Triton-X-100, 15 min, RT, washed in PBS, and blocked at RT for 1 h in 5%
FBS/PBS before being incubated with primary antibody [mouse anti-Hsp25,
rabbit anti-GFP ab290 Abcam; rabbit anti-Hsp25, Stressgen Biotechnologies
Corp; mouse anti-Oct4, Santa Cruz; anti-Foxa2(Hnf-3β) clone 4C7, DHSB,
Iowa] in 5% FBS/PBS, 1 h. The cells were washed three times in PBS and
incubated in 5% FBS/PBS with fluorophore conjugated secondary antibody
(goat anti-rabbit conjugated with AlexaFluor 488, goat anti-mouse conjugated
with AlexaFluor 594, Molecular Probes) for 1 h. After three washes in PBS,
they were washed for 5 min in 5 μg/ml Hoechst before being imaged on an
Axioskop 2 Plus microscope (Zeiss). Washes were performed by centrifugation
of spheres at 500 r.p.m. for 3 min.
2.12. Western blotting
Blots were incubated with primary antibody (anti-Hsp25, Stressgen
Biotechnologies Corporation; anti-α-tubulin, Sigma Aldrich), washed once for
5 min in 10% milk with PBS/0.1% Tween 20, and twice for 10 min in PBS and
0.1% Tween 20. Secondary antibody (goat anti-mouse/goat anti-rabbit
conjugated with HRP, Santa-Cruz) incubation was in 10% milk with PBS/
0.1% Tween 20 for 1 h before being washed once for 5 min in 10% milk with
PBS/0.1% Tween 20, and twice for 10 min in PBS/0.1% Tween 20.3. Results
3.1. Serum-free culture of ES cells generates high numbers of
neural precursors
In this study, we used the serum-free differentiation method
described by Bouhon and co-workers [2] in which ES cell-
derived free-floating aggregates, also called neurogenic
embryoid bodies (NEB)s, are cultured in chemically defined
media (CDM). This differentiation method generates a high
percentage of neural precursors within 4 days of culture in
CDM with a concomitant decrease in Pou5f1 (stem cell
marker) expressing cells [2,6]. Sox1 is an HMG box
transcription factor expressed in the early neurectoderm [13]
and is a marker for early neuronal precursor cells. Fig. 1 shows
the increase in proportion of Sox1 expressing cells in NEB
cultures as cells go from expressing no Sox1 in ES cell cultures
(Fig. 1A), and early NEB cultures (Fig. 1B), to higher levels
after 4 days in CDM (Fig. 1C). After 8 days, the majority of
cells express Sox1 (Fig. 1D) although this proportion is already
on the decline since around D6 cells start differentiating [2]. A
FACS profile of the proportion of Sox1 expressing cells during
CDM culture mirrors the immuno-cytochemical data and is
consistent with previous reports of Sox1 expression in serum-
free media (data not shown).
Fig. 1. Fluorescence microscopy of GFP expression in differentiating 46 C ES cells, in which GFP is expressed off the Sox1 promoter. The increase in GFP expression
(a marker for Sox1 expression) shows that neural differentiation progresses concomitantly with NEB formation. (A) Anti-GFP antibody (green). (B) Anti-GFP
antibody (green) on day 2 NEBs. (C) Anti-GFP antibody (green) on day 4 NEBs. (D) GFP expression (green) in day 8 NEBs and (D′) brightfield image of (D). Hoechst
staining in blue. Scale bars are 20 μm in panels A–C and 200 μm in panels D and D′. The tissue in panels A–C is fixed, therefore an anti-GFP antibody is required to
visualize the GFP because fixation strongly decreases its fluorescence.
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DIGE was used to identify changes in the highly soluble
fraction of the proteome of murine ES cells during their CDM
induced differentiation. This fraction represents the proteins
most amenable to analysis using 2D gel electrophoresis. Zoom
gels, of the narrow pH range of 5–8 were used rather than broad
range gels (pH range 3–10), to improve the number and
resolution of spots visualized in each gel. In total ten spots were
confirmed as being consistently and significantly altered in
normalized spot volume between ES and NEBs (see methods
section for significance verification). Six of these were identified
in Q-TOF mass spectrometry (MS) analysis and are listed in
Table 1. From 24 to 48 h into this analysis, a single spot with an
isoelectric point of between pH 6·5 and 7.0 (Mw of 23 kDa) was
shown to decrease in intensity approximately 3-fold in NEBsTable 1
Spot
Number
Q-TOF MS identification Accession number/database source
1 Hsp25 (down) AAA37862/locus MUSHSP25A1
2 Mortalin (down) AAB28641/AAB28641.1
3 Cytokeratin Endo A (down) AAA37551/locusMUSENDOAA acc
4/5 Voltage dependent Anion
Channel (VDAC) (up)
NP-035824/REFSEQ: acc NM01169
4/5 Prohibitin (up) NP-032857/ Refseq: acc.NM008831.
6 Vimentin (down) CAA39807/embl locus MMVMTM
Q-Tof MS results for spots identified as being significantly changed in normalized s
match is a random event. Scores over 51 indicate identity or extensive homology
regulation on differentiation.
a Peptide sequences for each peptide match: EGVVEITGK (47), SPSWEPFR
LFDQAFGVPR (42); numbers in parenthesis are peptide scores.relative to ES cells (Fig. 2). By day 4 the level of this decrease
had reached 9·5-fold compared to ES levels (Fig. 3, Table 2).
This spot was identified as the small heat shock protein, Hsp25
(accession: AAA37862, database source: locus MUSH-
SP25A1), using Q-TOF MS, which assigned this spot
identification with aMASCOTscore of 196 [the score represents
the probability that the match is a random event, a score of >51
indicates identity or extensive homology (p<0.05)].
This result was confirmed by Western blot analysis. Fig. 4A
shows a 1 dimensional (1D) immuno-blot of an SDS-PAGE
analysis of whole cell extracts, comparing the level of Hsp25 in
ES cells and day 4 NEBs. Western blotting was carried out on
equal amounts of protein using a polyclonal antibody to detect
Hsp25, and showed that whilst Hsp25 is abundant in
undifferentiated ES cells, it is barely detectable in day 4
NEBs. This result infers that a substantial reduction in the level
of Hsp25 occurs as ES cells lose pluripotency and commitScore Sequence
coverage
Total no. peptides
assigned
Molecular
weight (kDa)
196 31% 5 a 23
102 5% 3 75
.M21836.1 266 20% 9 54
4.1 198 27% 5 31
2 120 16% 3 30
189 15% 6 51
pot volume between ES and NEBs. The score represents the probability that the
(p<0.05). ‘Up’ or ‘down’ refers to whether the spot showed an up- or down-
(36), QLSSGVSEIR (50), YTLPPGVDPTLVSSSLSPEGTLTVEAPLPK (21),
Fig. 2. Difference gel electrophoresis images of ES cell and NEB samples separated on a 2D gel. 75 μg of ES and NEB sample, labeled with Cy3 and Cy5 respectively,
were loaded. The acidic side is to the left. Molecular weight decreases from top to bottom. Imaging was carried out using the ProXpress multi-wavelength imager
(Perkin Elmer), with Cy3 labeled protein visualized at 590 nm and Cy5 labeled protein at 680 nm.
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decrease in abundance, observed at day 4 by DIGE analysis,
may be an underestimate of the degree of change, as assessed by
western blotting.
3.3. Hsp25 levels are maintained during the first 24 h of NEB
formation
To confirm our DIGE result and further assess the level of
Hsp25 during early neural differentiation, Western blot analysis
was performed on whole cell lysates from ES cells, 6 h, 12 h
and 24 h NEBs. We did not observe a detectable change in the
level of Hsp25 between ES cells and these early NEB samples
(Fig. 4B).
Mehlen and co-workers [10] demonstrated that Hsp25 levels
decrease during endodermal differentiation of CGR8 murine ES
cells. However, they noted that Hsp25 transiently accumulates,
peaking at 24 h following differentiation, to a level 2.5-fold
greater than that detected in undifferentiated ES cells. In
contrast to the data on endodermal differentiation, in the DIGE
analysis performed here on cells directed along a neuroecto-
dermal pathway, we did not detect any significant changes in
abundance of Hsp25 levels 24 h following the differentiation of
ES cells with CDM.
3.4. Hsp25 is present as three forms in ES cells
2D immunoblots were used to determine the expression
patterns of Hsp25 species that may be present in undifferen-
tiated ES cells and up to day 4 NEBs following CDM induced
differentiation. Equivalent amounts of ES cell and day 4 NEB
whole cell lysates were separated using 2D gels and probed
with anti-Hsp25 antibody. Three species of Hsp25 were
identified in ES cells (Fig. 5A). Species A constitutes the
major population of Hsp25 in ES cells, having the most basic
pI value of the three spots. Species B appears as a faint spot
that is barely detectable and makes up a very small proportionof the Hsp25 population, while species C has the most acidic
pI. From its level of abundance, we suggest that spot A is the
spot originally identified by DIGE analysis, having an
approximate pI value of between 6.5 and 7.0 (as determined
by DIGE), which is close to the predicted native pI value for
Hsp25 of 6.53.
3.5. Two species of Hsp25 are expressed in early NEBs
To assess whether early neuroectodermal differentiation is
associated with changes in expression of the three species
expressed in ES cells, 2D immunoblots were run of ES cells,
6, 12 and 24 h NEBs and probed with antibody to Hsp25 (Fig.
5B–D). Two species of Hsp25 are seen following the CDM
induction of ES cells. The minor species B is exclusively
detected in ES cells, while species A and C are detected at all
time points studied during the first 24 h of NEB formation. No
Hsp25 can be detected in 2D immunoblots in day 4 NEBs
(Fig. 5E).
The expression of various species of Hsp25 during
neuroectodermal differentiation differs from that observed
during endodermal differentiation [10], since two species are
clearly visible during the initial 24 h of neural differentiation
while only one species is reported during endodermal
differentiation. Protein modifications that could potentially
result in the expression of these three species were not studied.
3.6. Hsp25 expression becomes restricted in NEBs
We carried out indirect immunocytochemistry (IC) to assess
whether the decrease of Hsp25 in differentiating NEBs was
associated with a specific cell type. Hsp25 was expressed in the
majority of ES cells and was localized almost exclusively to the
cytoplasm (Fig. 6A). A similar pattern of localization was
observed for the cell line E14 (using a polyclonal antibody to
Hsp25) (data not shown). By day 4, no overlap in expression
was detected between Hsp25 and the marker for neural
Fig. 3. (A) Cropped and enlarged images of three DIGE gels showing the spot identified as Hsp25. Each DIGE gel is presented as an ES sample image (top) positioned
above the corresponding NEB sample image (day 1, day 2 or day 4) taken from the same gel. The relative difference in spot intensity seen between each gel set is due to
gel to gel variation, meaning visual inter-gel comparisons are not possible (however, DIGE allows two samples to be separated on a single gel, thereby eliminating
many gel reproducibility issues, allowing images from a single gel to be directly compared). During software analysis, internal normalization is performed on each
image, and the expression ratio derived between corresponding spots from images in a single gel represents the relative change in protein abundance. A spot that lies
below Hsp25, also disappeared following ES cell differentiation. However, no conclusive MS identification was made for this protein. (B) Graph showing the
expression of Hsp25 in day 1, day 2 and day 4 NEBs, relative to expression in ES cells. Expression is displayed as the average normalized spot volume ratio for each
time point. The normalized spot volume represents the relative abundance of protein within a spot; the ratio of normalized spot volumes between corresponding spots
in a DIGE gel equates to changes in abundance of protein within that spot. This was given a positive or negative value depending upon whether expression was
increased (positive value) or decreased (negative value) in NEB compared to ES sample. The two horizontal lines at y=0.29 and y=−0.29 represent the average
threshold values beyond which normalized spot volume ratios are considered significant. This represents the average of the Cy 5 and Cy3 threshold values calculated in
control gels.
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expressing cells from neuronal precursors suggests that Hsp25
is switched off in cells which commit to a neuronal lineage. In
day 2 NEBs, some cells still express the stem cell marker
Pou5f1; no tight correlation of expression pattern was observed
between Pou5f1 expressing cells and the cells still expressing
Hsp25. Although we observed many cells expressing both
Pou5f1 and Hsp25, there were some cells that expressed each
protein independently of the other (Fig. 6C). Bouhon and co-
workers [2] identified a transient population of non-neural cells
in some NEBs that expressed markers of the node and primitive
endoderm, including Foxa2 (representing 7–10% of all cells in
day 8 NEBs). We wanted to determine if the down-regulation of
Hsp25 was specific to cells differentiating down a neural
lineage, or if indeed its down-regulation was more general upon
differentiation along alternative routes. Indirect co-immunoflu-
orescence between Hsp25 and Foxa2 was carried out at 4 daysfollowing culture in CDM. Not all NEBs contain Foxa2
expressing cells, but those that did showed virtually no-overlap
between Hsp25 and Foxa2 expressing cells (Fig. 6D). We
suggest that the down-regulation of Hsp25 may be a more
general phenomenon following differentiation.
As in ES cells, Hsp25 still present in cells in NEBs had a
cytoplasmic localization (Fig. 6B, C). This exclusive cytoplas-
mic localization of Hsp25, despite changes in media conditions,
is in contrast to the translocation of Hsp25 that takes place in
cells exposed to certain cellular insults such as the cytoplasm to
nuclear shift seen with heat shock [14] or oocyte maturation
[15].
4. Discussion
Proteomic analysis has proven to be a powerful approach for
the identification of differentially expressed proteins, and for the
Fig. 5. Expression of Hsp25 in ES cells, 6, 12, 24 h NEBs and day 4 NEBs.
100 μg of whole cell lysate from ES cells (A), 6 h NEBs (B), 12 h NEBs (C),
24 h NEBs (D) and day 4 NEBs (E) was separated using 2D gel electrophoresis
(1st dimension: IEF pH 5–8, 2nd dimension: 12% SDS PAGE). Immunoblotting
was carried out with Hsp25 polyclonal anti-body. Only the relevant section of
gel is presented. The acidic end is to the left.
Table 2
aNormalized spot volume ratios for Hsp25 across all the gels of the screen that
were used to generate the graph in Fig. 3. The ratio represents the fold increase
or decrease in expression of Hsp25 in NEBs compared to ES cells. Ratios
greater than the significance threshold are highlighted in grey.
bNo significant change in Hsp25 expression was seen in day 1 NEBs, relative to
ES cells but in day 2 and day 4 NEBs, expression decreased by approximately
3-fold and 9·5-fold respectively.
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proteomic screens carried out to study retinoic acid induced
neuronal differentiation of P19 cells have revealed a number of
proteins that were up-regulated during this process [16,17].
Interestingly, in one of these studies, no down-regulation of
proteins was observed [16].
We carried out a differential analysis of the highly soluble
fraction of the proteome and the identities of the proteins
detailed in Table 1 are a reflection of this sub-population. These
species are most amenable to 2D gel analysis, not only in terms
of their solubility but also their abundance. Consequently, this
screen was not exhaustive, and represents a fraction of the
global protein changes as ES cells differentiate under conditions
that predominantly favour neural differentiation.
One of the most striking changes in protein abundance
observed during this process was found to be that of the small
heat shock protein (sHsp) Hsp25 (HspB1, Hsp27 in human),
which is expressed in mammalian development and in response
to cellular stress [18,19]. Hsp25 is typical of many sHsps, in that
it has been shown to exist in vivo in a range of oligomeric statesFig. 4. (A1) Western blot showing differential expression of Hsp25 in ES cells and
separated using 12% SDS PAGE and immunoblotted with anti-Hsp25 polyclonal anti
Consistent expression of Hsp25 in ES cells, 6 h, 12 h and 24 h NEBs. 10 μg whole ce
PAGE and immunoblotted with anti-Hsp25 polyclonal antibody. (B2) The blot wasand as a number of different phospho-forms [20–22].
Phosphorylation events can result in the formation of both
smaller and larger oligomers, which provide cyto-protection byday 4 NEBs. 10 μg of whole cell extract from ES cells and day 4 NEBs was
body. (A2) Equal loading was confirmed by re-probing with anti-α-tubulin. (B1)
ll extract from ES cells, 6 h, 12 h and 24 h NEBs was separated using 12% SDS
re-probed with anti-α-tubulin to confirm equal loading.
Fig. 6. Fluorescence microscopy showing expression of Hsp25 and markers of neural precursors (Sox1), pluripotency (Pou5f1) and primitive endoderm (Foxa2) in ES
cells and differentiating NEBs at day 2 and day 4. (A) Immunofluorescence (IF) showing Hsp25 localization in ES cells (cell line 46C): from left to right, combined
image for Hsp25 and Hoechst (red, blue), anti-Hsp25 (red), Hoechst stained nuclei (blue). (B) Co-IF between Hsp25 and GFP (to visualise Sox1-GFP) in
differentiating NEBs at day 4 (cell line 46C). From left to right, combined GFP and Hsp25 (green and red), anti-GFP (green), anti- Hsp25 (red), Hoechst (blue). (C) Co-
IF between Hsp25 and Pou5f1 on NEBs at D2 (cell line E14). From left to right, combined Hsp25 and Pou5f1 (green and red), anti-Hsp25 (green), anti-Pou5f1 (red),
Hoechst stained nuclei (blue). (D) Co-IF between Hsp25 and Foxa2 at D4 (cell line 46C). From left to right, combined Hsp25 and Foxa2 (green and red), anti-Hsp25
(green), anti-Foxa2 (red), Hoechst stained nuclei (blue). Scale bar in panel A is 100 μm and in panels B–D is 10 μm.
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and as anti-apoptotic factors [23–25]. sHsps are found to be
constitutively expressed in many cells including the murine ES
cell line CGR8 [10].
Differential expression and/or phosphorylation of Hsp25
has been shown in a number of differentiation processes, for
example cardiomyocyte differentiation in P19 embryonal
carcinoma (EC) cells and endodermal differentiation in
CGR8 ES cells [10,11]. In a number of these reports, the
level of Hsp25 has been correlated with a reduction in the
level of cell proliferation [10,26,27]. However, the function
and mechanism behind Hsp25 involvement during differenti-
ation remains unknown. Tissue specific expression of Hsp25
during mouse development has also been shown, including in
the nervous system [28,29]. In line with this a number of
groups have investigated the role of Hsp25 during in vitro
neural differentiation. Stahl and co-workers [30] found that
Hsp25 is up-regulated as P19 embryonal carcinoma (EC) cells
differentiate in response to retinoic acid. Davidson and
Morange [11] showed that although levels of Hsp25 were
high in the undifferentiated EC cells, the protein could not be
detected in post-mitotic neurones (using TuJ1 marker). It is
possible that the up-regulation of Hsp25 identified by Stahl
and co-workers using immunoblots may have been influencedby a contaminating population of endodermal cells [11]. In rat
olfactory neurones, which in contrast to P19 derived neurones
[31], represent a more restricted sub-population, Hsp27 levels
appear to increase during their dopamine mediated differen-
tiation. Reducing expression of Hsp27 using antisense
technology results in inhibition of this process [10]. The
reason for the disparity in results on the expression of Hsp25/
27 between this study and previous studies is not obvious. We
suggest that the observed differences may arise due to the use
of different cell lines, following alternative courses of
differentiation i.e. endodermal versus neuroectodermal. Fur-
ther discord in results may also be introduced as a result of
varying expression of Hsp25/27 in different differentiation
products, for example, we observed no expression in NEBs
(the early precursor cells), whereas studies in specific sub-
populations of post-mitotic neurons have indeed detected
Hsp25/27 expression [31].
Stem cell differentiation is complex and involves the
restriction and activation of new protein expression. Recent
work on protein expression levels suggests that stem cell
differentiation involves the restriction of protein expression
rather than the addition of newly expressed genes [32] such that
stem cells express many more proteins than their progeny. We
show that Hsp25 protein levels decrease following CDM
155A. Battersby et al. / Biochimica et Biophysica Acta 1773 (2007) 147–156induced differentiation of murine ES cells and that expression of
Hsp25 becomes excluded from neurogenic precursors. This
serves as an example of restriction of protein expression
as stem cells differentiate. Whilst this screen was set up to
identify candidates that altered expression following neural
differentiation (this being the major pathway followed during
serum-free culture of ES cells), we also found that Hsp25 is
excluded from the transient non-neural population found in
early NEBs and identified by Foxa2 expression. We suggest that
Hsp25 down-regulation may be an early marker of stem cell
differentiation, being apparent (within 2 days in serum-free
culture) before overt expression of differentiation markers (e.g.
Sox1 is apparent at 4 days). The changes in expression of Hsp25
species that occur following differentiation of ES cells to NEBs
are likely to reflect the changes in Hsp25 species during neural
induction since this is the major differentiation pathway
followed upon serum-free culture. This may also be reflected
in the differences observed in Hsp25 species expressed in this
study (predominantly neuroectodermal differentiation) and
those observed during endodermal differentiation [10]. At the
moment there is no mechanistic link between neurogenesis and
the many cellular functions of Hsp25 and the significance of its
rapid reduction during ES cell differentiation remains to be
studied.
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